FB2026_03 , released September 17, 2026
Human Disease Model Report: multiple sulfatase deficiency
Open Close
General Information
Name
multiple sulfatase deficiency
FlyBase ID
FBhh0001126
Disease Ontology Term
Parent Disease
Overview

This report describes a potential model of multiple sulfatase deficiency (MSD); MSD exhibits autosomal recessive inheritance. The gene implicated in this disease is sulfatase-modifying factor 1 (SUMF1), which is required for posttranslational modification and catalytic activation of sulfatase enzymes. There is a single orthologous gene in Drosophila, CG7049, for which an amorphic allele created by targeted recombination and RNAi-targeting constructs have been generated. CG7049 is also orthologous to the human gene SUMF2.

The human SUMF1 gene has not been introduced into flies.

A human disease model report has been created for this potential model because variants analogous to disease-implicated mutations in the human SUMF1 gene have been introduced into Dmel\CG7049 by homologous recombination; however, they have not yet been characterized. Variant(s) implicated in human disease introduced (as analogous mutation in fly gene): S131P in the fly CG7049 gene (corresponds to S155P in the human SUMF1 gene); R312C in the fly CG7049 gene (corresponds to R345C in the human SUMF1 gene). A large number of physical interactions have been described for CG7049; see below and in the CG7049 gene report.

[updated Nov. 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: multiple sulfatase deficiency
OMIM report

[MULTIPLE SULFATASE DEFICIENCY; MSD](https://omim.org/entry/272200)

Human gene(s) implicated

[SULFATASE-MODIFYING FACTOR 1; SUMF1](https://omim.org/entry/607939)

Symptoms and phenotype

Multiple sulfatase deficiency is an autosomal recessive inborn error of metabolism resulting in tissue accumulation of sulfatides, sulfated glycosaminoglycans, sphingolipids, and steroid sulfates. Affected individuals show neurologic deterioration with mental retardation, skeletal anomalies, organomegaly, and ichthyosis. Different types of MSD can be distinguished according to the age of onset: neonatal, late infantile (0 to 2 years), and juvenile (2 to 4 years). Earlier onset correlates with more severe phenotypes. [from MIM:272200; 2019.11.02]

Genetics

Multiple sulfatase deficiency (MSD) is caused by homozygous or compound heterozygous mutation in the sulfatase-modifying factor-1 gene (SUMF1). [from MIM:272200; 2019.11.02]

Cellular phenotype and pathology
Molecular information

The SUMF1 gene encodes an enzyme required for posttranslational modification and catalytic activation of the family of sulfatase enzymes. The enzymatic defect affects the whole family of sulfatase enzymes. [from MIM:607939 and MIM:272200; 2019.11.02]

External links
Disease synonyms
MSD
mucosulfatidosis
Search term: lysosomal storage disorder
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 2 human to 1 Drosophila.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Cellular component (GO)
      Gene Groups / Pathways
      Comments on ortholog(s)

      High-scoring ortholog of human SUMF1; lower scoring ortholog of SUMF2 (1 Drosophila to 2 human). Dmel\CG7049 shares 40-44% identity and 53-56% similarity with the human genes.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (31 groups)
        protein-protein
        Interacting group
        Assay
        References
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        amorphic allele - molecular evidence
        CRISPR/Cas9
        References (5)